Healthcare -
Biotechnology - NASDAQ - US
$ 129.12
1.24 %
$ 6.3 B
Market Cap
-21.52
P/E
AXSM - CHANGE IN WORKING CAPITAL
Change in Working Capital AXSM - Axsome Therapeutics, Inc.
33.9 M
LAST VALUE
19.68%
2 YEAR CAGR
17.45%
5 YEAR CAGR
52.01%
10 YEAR CAGR